Type 2 diabetes mellitus: a disease of the innate immune system? An update

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Diabetic Medicine

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1464-5491.2003.01030.xPMID 15008827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

  2005cited by this paper
• Effect of Short-Term Aspirin Use on C-Reactive Protein

  2004cited by this paper
• Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.

  2003cited by this paper
• C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

  2003cited by this paper
• C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

  2002cited by this paper
• High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.

  2002cited by this paper
• Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women

  2002cited by this paper
• PPARgamma and vascular inflammation: adding another piece to the puzzle.

  2002cited by this paper
• Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes.

  2002cited by this paper
• Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year

  2002cited by this paper
• Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

  2002cited by this paper
• Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

  2002cited by this paper
• Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994.

  2002cited by this paper
• Does Exercise Reduce Inflammation? Physical Activity and C-Reactive Protein Among U.S. Adults

  2002cited by this paper
• PPARγ and Vascular Inflammation: Adding Another Piece to the Puzzle

  2002cited by this paper
• Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

  2002cited by this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cited by this paper
• Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults.

  2002cited by this paper
• Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.

  2002cited by this paper
• Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

  2002cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Gamma globulin levels predict type 2 diabetes in the Pima Indian population.

  2001cited by this paper
• New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering

  2001cited by this paper
• C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites

  2001cited by this paper
• Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

  2001cited by this paper
• New evidence for beneficial effects of statins unrelated to lipid lowering.

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Pro-inflammatory cytokines and adipose tissue

  2001cited by this paper
• The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.

  2001cited by this paper
• [Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study].

  2001cited by this paper
• C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

  2001cited by this paper
• C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease.

  2001cited by this paper
• Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors.

  2001cited by this paper
• Novel clinical markers of vascular wall inflammation.

  2001cited by this paper
• The relation of body fat mass and distribution to markers of chronic inflammation

  2001cited by this paper
• Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

  2001cited by this paper
• The response of serum sialic acid and other acute phase reactants to an oral fat load in healthy humans.

  2001cited by this paper
• Association of C-reactive protein with markers of prevalent atherosclerotic disease.

  2001cited by this paper
• Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

  2000cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

  2000cited by this paper
• Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency

  2000cited by this paper
• C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

  1999cited by this paper
• Body mass index, diabetes, and C-reactive protein among U.S. adults.

  1999cited by this paper
• Serum sialic acid in a random sample of the general population.

  1999cited by this paper
• Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.

  1999cited by this paper
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

  1999cited by this paper
• Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.

  1999cited by this paper
• Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

  1999cited by this paper
• C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

  1999cited by this paper
• Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH‐deficiency: a double‐blind placebo‐controlled study

  1999cited by this paper
• Nutritional modulation of cytokine biology.

  1998cited by this paper
• Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals.

  1998cited by this paper
• Serum Sialic Acid, a Reputed Cardiovascular Risk Factor, is Elevated in South Asian Men Compared to European Men

  1998cited by this paper
• Periodontal disease and diabetes mellitus: a two-way relationship.

  1998cited by this paper
• Is Type II diabetes mellitus a disease of the innate immune system?

  1998cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Somatostatin Receptor SST4 in Human Placenta and Absence of Octreotide Effect on Human Placental Growth Hormone Concentration during

  1997cited by this paper
• Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

  1997cited by this paper
• Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

  1997cited by this paper
• Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-α function

  1997cited by this paper
• Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids.

  1997cited by this paper
• Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice

  1997cited by this paper
• Raised Serum Sialic Acid Concentration in NIDDM Patients With and Without Diabetic Nephropathy

  1996cited by this paper
• Raised Serum Sialic Acid Concentration Precedes Onset of Microalbuminuria in IDDM: A 10-year follow-up study

  1996cited by this paper
• The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases.

  1996cited by this paper
• Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease.

  1996cited by this paper
• Microalbuminuria in patients with rheumatoid arthritis.

  1995cited by this paper
• Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM

  1995cited by this paper
• Plasma and Urine Sialic Acid in Non-Insulin Dependent Diabetes Mellitus

  1995cited by this paper
• The Urinary Concentration of Sialic Acid is Increased in Non‐insulin‐dependent Diabetic Patients with Microangiopathy: a Possible Useful Marker for Diabetic Microangiopathy

  1995cited by this paper
• Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.

  1995cited by this paper
• Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

  1995cited by this paper
• A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

  1995cited by this paper
• The acute phase response: general aspects.

  1994cited by this paper
• Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

  1994cited by this paper
• The relationship of serum total sialic acid with serum acute phase proteins and lipoprotein (a) in patients with severe hypertriglyceridaemia

  1994cited by this paper
• Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers.

  1993cited by this paper
• Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus.

  1993cited by this paper
• Elevated Serum Sialic Acid Concentration in NIDDM and Its Relationship to Blood Pressure and Retinopathy

  1993cited by this paper
• Serum sialic acid and acute-phase proteins in hypertriglyceridaemic patients showing the Frederickson's type IIB phenotype.

  1993cited by this paper
• Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes.

  1992cited by this paper
• Role of Cytokines in Inducing Hyperlipidemia

  1992cited by this paper
• Relation of serum sialic acid to lipid concentrations.

  1992cited by this paper
• Serum sialic acid concentration and cardiovascular mortality.

  1991cited by this paper
• Insulin modulation of acute-phase protein production in a human hepatoma cell line.

  1991cited by this paper
• Increased levels of acute-phase serum proteins in diabetes.

  1989cited by this paper
• Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy.

  1988cited by this paper
• Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

  1987cited by this paper
• [6] Characterization of sialic acids

  1978cited by this paper
• Characterization of sialic acids.

  1978cited by this paper
• Blood glycoprotein levels in diabetes mellitus

  1976cited by this paper
• Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus.

  1967cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo*

  year unknowncited by this paper

• The role of suPAR and related proteins in kidney, heart diseases, and diabetes

  2026cites this paper
• Interleukin-4 ameliorates macrophage lipid stress through promoting cholesterol efflux and lipid homeostasis.

  2025cites this paper
• Morin Modulates the Activities of Pro-inflammatory Enzymes and Expression of Cytokines and Nuclear Factor Kappa B in the Heart, Liver, and Pancreas in Streptozotocin-induced Diabetic Rats

  2025cites this paper
• Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs

  2025cites this paper
• Glycated Hemoglobin: a promising biomarker for predicting acute exacerbation and short-term mortality of chronic obstructive pulmonary disease

  2025cites this paper
• Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions

  2024cites this paper
• Exploring carrageenan: From seaweed to biomedicine-A comprehensive review.

  2024cites this paper
• Fiery Connections: Macrophage-Mediated Inflammation, the Journey from Obesity to Type 2 Diabetes Mellitus and Diabetic Kidney Disease

  2024influential citation
• Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis

  2023cites this paper
• INFLAMMATION IN NEWLY DIAGNOSED DIABETES PATIENTS

  2023cites this paper
• Targeting the CCL2-CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases.

  2023cites this paper
• High sensitivity C‐reactive protein and prediabetes progression and regression in middle‐aged and older adults: A prospective cohort study

  2023cites this paper
• Modulation of Altered Immune Parameters IL-2 and TNF-α in Diabetic Animal Models: A Therapeutic Insinuation of Metformin Beyond Diabetes

  2023cites this paper
• Relationship between serum sialic acid level and Diabetic neuropathy in Egyptian patients with type 2 Diabetes Mellitus

  2023cites this paper
• Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

  2023cites this paper
• Salivary Immune Parameters as A Predictor of Oral Diseases

  2023cites this paper
• Association of hsCRP with Serum Creatinine in Type 2 Diabetic Patients at Tertiary Care Hospital

  2023cites this paper
• Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.

  2023cites this paper
• Investigation of serum level relationship anti-glutamic acid decarboxylase antibody and inflammatory cytokines (IL1-β, IL-6) with vitamins D in type 2 diabetes

  2022cites this paper
• Evaluation of progression in metabolic parameters along with markers of subclinical inflammation and atherosclerosis among normoglycemic first degree relatives of type 2 diabetes mellitus patients

  2022cites this paper
• Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus

  2022cites this paper
• Anti-Inflammatory, Fibrinolytic and Anti-Oxidant Activities of the N-Hexane Extract of Ficus sur Forssk (Moraceae) Leaves

  2022cites this paper
• What is the role of heat shock protein in abdominal organ transplantation?

  2022cites this paper
• The Shadow of the Neolithic Revolution on Life Expectancy: A Double-Edged Sword

  2022cites this paper
• Pro-Gly Based Dipeptide Containing Sulphonamide Functionality, their Antidiabetic, Antioxidant, and Anti-inflammatory Activities. Synthesis, Characterization and Computational studies

  2022cites this paper
• Role of C-Reactive Protein in Diabetic Inflammation

  2022cites this paper
• Association of visceral fat with cardiopulmonary fitness, oxidative stress and inflammatory markers in asymptomatic individuals with and without family history of type 2 diabetes mellitus

  2022cites this paper
• 3D bioprinting as a designer organoid to assess pathological processes in translational medicine

  2022cites this paper
• Prevalence and co-existence of cardiometabolic risk factors and associations with nutrition-related and socioeconomic indicators in a national sample of Gambian women

  2021cites this paper
• Relationship between serum sialic acid concentration and diabetic nephropathy in Egyptian patients with type 2 diabetes mellitus

  2021influential citation
• Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects

  2021cites this paper
• Evaluating the effect of hydro-alcoholic extract of Phoenix dactylifera L. spathe on streptozotocin-induced diabetic rats

  2021cites this paper
• Glycated Hemoglobin (HbA1c) as a Predictor of Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Identification of MDM2, YTHDF2 and DDX21 as potential biomarkers and targets for treatment of type 2 diabetes.

  2021cites this paper
• Evaluation of Association Between Serum Magnesium and Serum Lipid Profile in Type 2 Diabetes Mellitus

  2021cites this paper
• Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes

  2021influential citation
• MicroRNAs and Their Delivery in Diabetic Fibrosis.

  2021cites this paper
• The Platelet–Lymphocyte Ratio Associated with Depression in Diabetes Patients in the US National Health and Nutrition Examination Survey

  2021cites this paper
• Identification of potential biomarkers and molecular mechanisms in the development of type 2 diabetes

  2021cites this paper
• Salivary and Serum Levels of IL-6 and IL-8 in Diabetic Patients with Periodontal Disease: A Review Article

  2020cites this paper
• The monocyte-to-lymphocyte ratio and depression in diabetes patients

  2020cites this paper
• Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis

  2020cites this paper
• Insulin-Like Proteins in Plant Sources: A Systematic Review

  2020cites this paper
• DMSO_A_238942 1015..1021

  2020cites this paper
• The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders

  2020cites this paper
• The Association between Metabolic Syndrome and Multiple Myeloma

  2020cites this paper
• Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function

  2020cites this paper
• Inflammatory Targets in Diabetic Nephropathy

  2020cites this paper
• DMSO_A_256883 3421..3431

  2020cites this paper
• Association of Betatrophin, TNF-α and IL-6 with diabetic microvascular and macrovascular complications

  2020cites this paper
• TLR4 Polymorphisms (896A>G and 1196C>T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus

  2020cites this paper
• Polydatin-loaded chitosan nanoparticles ameliorates early diabetic nephropathy by attenuating oxidative stress and inflammatory responses in streptozotocin-induced diabetic rat

  2020cites this paper
• Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective

  2020cites this paper
• Correlational study of interleukin-6 with albuminuria in type 2 diabetes mellitus

  2019cites this paper
• n-3 Polyunsaturated Fatty Acids in Type 2 Diabetes Mellitus

  2019cites this paper
• Correlation of inflammatory marker High-sensitive C-reactive protein (Hs-CRP) with risk factors of nephropathy in type 2 diabetes

  2019cites this paper
• Pathogenetic Mechanism of Type 2 Diabetes Mellitus and its Clinical Implications

  2019cites this paper
• Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders

  2019cites this paper
• Potential roles of chromium on inflammatory biomarkers in diabetes: A Systematic

  2019cites this paper
• Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.

  2019cites this paper
• The Association of Serum hsCRP and Urinary Alpha1-Microglobulin in Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation

  2018cites this paper
• The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration.

  2018cites this paper
• Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease

  2018cites this paper
• Evaluation of the Serum Levels of IL-1 in Type 2 Diabetic Patients with and without Diabetic Nephropathy

  2018cites this paper
• Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease

  2018cites this paper
• The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine

  2018cites this paper
• CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology

  2018cites this paper
• Evaluation of the anti-diabetic potentials of some African medicinal plants: a multimode study.

  2018cites this paper
• Mediterranean Diet, Glucose Homeostasis, and Inflammasome Genetic Variants: The CORDIOPREV Study

  2018cites this paper
• Atherogenic Index and Female Gender are Independent Determents of Chronic Subclinical Inflammation in Subjects with Type 2 Diabetes Mellitus

  2017cites this paper
• Metabolic Syndrome in Long‐Term Survivors of Hematopoietic Stem‐Cell Transplantation

  2017cites this paper
• Antidiabetic and anti-inflammatory potential of sulphated polygalactans from red seaweeds Kappaphycus alvarezii and Gracilaria opuntia

  2017cites this paper
• Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality

  2017cites this paper
• Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism

  2017cites this paper
• Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways

  2017cites this paper
• Evaluation of C-Reactive Protein Levels amongst Patients of Diabetic Nephropathy in Rural Tertiary Care Centre of Central India

  2017cites this paper
• From obesity through immunity to type 2 diabetes mellitus

  2017cites this paper
• Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis.

  2017cites this paper
• Influence of Life Style, Nutrition and Obesity on Immune Response: A GlobalIssue

  2017cites this paper
• Antioxidative and Anti-Inflammatory Activities of Galloyl Derivatives and Antidiabetic Activities of Acer ginnala

  2017cites this paper
• Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes

  2016cites this paper
• Association between Toll-Like Receptor 4 and Occurrence of Type 2 Diabetes Mellitus Susceptible to Pulmonary Tuberculosis in Northeast China

  2016cites this paper
• Non Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus and Metabolic Syndrome: the Role of Low-grade Systemic Inflammation Serum Markers ofF Autoimmune Thyroiditis in Euthyroid Women with Polycystic Ovary Syndrome

  2016cites this paper
• Characterization of inter-animal variation in the innate immune response of the bovine and its relation to S. aureus mastitis.

  2016cites this paper
• Resveratrol Inhibits the Production of Reactive Oxygen Species in Phorbol Ester- and Toll-Like Receptor-Stimulated Granulocytes from Diabetic Patients

  2016cites this paper
• The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.

  2016cites this paper
• Elevated Interleukin-17 Levels in Patients with Newly Diagnosed Type 2Diabetes Mellitus

  2016cites this paper
• Systemic inflammatory responses in patients with type 2 diabetes with chronic periodontitis

  2016influential citation
• Amelioration of chronic inflammation and oxidative stress indices in diabetic Wistar rats using methanol leaf extract of Bridelia micrantha (Hochst) Baill. (Euphorbiaceae)

  2015cites this paper
• Cow-to-cow variation in fibroblast response to a toll-like receptor 2/6 agonist and its relation to mastitis caused by intramammary challenge with Staphylococcus aureus.

  2015cites this paper
• Value of Urinary Cystatin C In Early Detection Of Diabeticnephropathy In Type 2 Diabetes Mellitus

  2015cites this paper
• Assessment of hs-CRP with Serum Urea in Type-2 Diabetic Patients in Pokhara, Nepal

  2015cites this paper
• The prevalence of the red cell morphology changes in patients with type 2 diabetes mellitus.

  2015cites this paper
• Relationship between Fatty Acid Habitual Intake and Early Inflammation Biomarkers in Individuals with and without Type 2 Diabetes in Mexico.

  2015cites this paper
• Relationship between Serum Sialic Acid and Hemostatic Markers in Patients with Type 2 Diabetes Mellitus.

  2015cites this paper
• Markers of Oxidative Stress in Pregnant Women with Sleep Disturbances.

  2015cites this paper
• Group B streptococcus infections of soft tissue and bone in California adults, 1995–2012

  2015cites this paper
• Correlation of hs-CRP with environmental risk factors of nephropathy in type 2 diabetes

  2015cites this paper
• Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase

  2015cites this paper